XTL Biopharmaceuticals Ltd.

Regulatory Filings • Aug 28, 2008

_________ false

C007��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996428Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: rcohen@xtlbio.comDate of transmission: 28/08/2008              Time of broadcast: 09:08 08:48:25

Reference: 2008-02-248616

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 02/10/2008 at 15:00 the corporation will hold it's special meetingat Building 3, Kiryat Weizmann Science Park, PO Box 370, Rehovot 76100, IsraelNumber of the security that entitles its holder to vote at the meeting: 108549The Number - as given by the Tel Aviv Stock Exchange

According to section 182 _________ of the Companies law, 5759-1999, only shareholders of record at the close of business 25/08/2008 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report NoticeofEGMFinal_isa.pdf

Attached hereto is the proxy statement ProxyFormFinal_isa.pdf

The Company shall hold Two Extraordinary Meetings on 02/10/2008.Please Notice that the first Extraordinary meeting shall be held at 15:00, and the second Extraordinary meeting shall be held at 17:30. The attached Notice and Proxy statement relates to both Extraordinary meetings.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 21/07/2008
- - -
Name of the Signatory: : Kantor Ronen , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary , Name of Employer Company: .
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2